Christopher Williams Email and Phone Number
Christopher Williams work email
- Valid
- Valid
Christopher Williams personal email
I am a seasoned business executive with 29+ years of business development and marketing experience in the biotechnology and biopharma sectors. Recognized for demonstrating a natural aptitude for serving as a dynamic leader that is strongly committed to working with teams to achieve organizational goals, as well as for adding value to companies by building SAB/KOL boards, and driving performance through people and processes, I have a verifiable history of contributing directly to company growth and expansion throughout my career. Professional focal points include biotechnology, product development, marketing management, sales operations, client service, team leadership, non-profit advocacy, market analysis, molecular biology, life sciences, oncology, biochemistry, biopharmaceuticals, cross-functional team collaboration, technology solutions, and project management. Delivering superior administration on the latter areas of expertise requires the utilization of effective communication skills, negotiation skills, as well as business acumen, systems analysis, and resource management to support efficiency and maximum returns. Currently, I am the VP Business Development/Alliance Management with the Multiple Myeloma Research Foundation. Under my leadership, I drive continuous organizational growth by nurturing relationships in pharma, biotech, and technology. In addition, I liaise with senior leadership, stakeholders, and internal teams to ensure the organization’s support structure is driving the business forward with minimal expenditures.Colleagues describe me as a progressive, driven, down-to-earth, scientific, and managerial expert who can be relied on to offer superior solutions that deliver profitable results on time.
-
Vp Business Development/Alliance ManagementMultiple Myeloma Research Foundation - Mmrf May 2017 - PresentNorwalk, Connecticut, Us• Direct all facets of business relationships with pharma, biotech, and technology partners to create continuing opportunities.• Cultivate and maintain relationships with cross-functional partners, negotiate various contracts and deals.• Oversee the technology development of an online patient-facing registry.• Secured and completed multiple technology contracts in areas such as NGS, EMR/EHR extraction, AI analysis, mobile phlebotomy, and multiple outside consultants.• Chair and administer various grant programs for both academic medical centers and technology partners. • Maintain responsibility for managing ongoing relationships with top pharma and biotech partners in all areas, including research, patient education, and events.• Close new business and develop negotiating strategies by coordinating goals and requirements with company objectives and procedures.• Remain accountable for the coordinated management of multiple related projects directed toward strategic business and other organizational objectives.• Build credibility, establish rapport, and maintain communication with academic, corporate and governmental clients at the highest levels.
-
Vp Business DevelopmentWavesense Nov 2015 - Jan 2017• Spearheaded various business development efforts, including product support, market analysis, product menu expansion, and strategic partnerships.• Collaborated with Sales to identify and gain an audience with leading labs for product introduction.• Completed CE-IVD mark and registration of products in the EU and Turkey.• Appraised and reviewed new and existing technologies for competitive analysis purposes.• Remained abreast of the current disease markets, identified new biomarkers for potential product opportunities.• Initiated and closed agreements for various business segments.• Fostered and developed new business and strategic partnerships in the clinical diagnostics market.• Served as a key contributor in the strategic planning and execution of sales and marketing activities.• Engaged and encouraged emerging leaders, developing a goal-oriented mindset with accountability to personal and professional development.
-
Vp Business DevelopmentSkylinedx Bv Jan 2014 - Oct 2015Rotterdam, Zuid-Holland, Nl• Headed US commercialization strategy for the Oncology Product portfolio.• Identify and initiate CLIA laboratory implementation of products and services.• Captured key research/clinical partnerships with leading academic/pharmaceutical laboratories.• Devised and developed a comprehensive billing and reimbursement strategy for the US market.• Establish scientific advisory board/KOL relationships/speaker board.• Established world class SAB in Multiple Myeloma space• Established network of KOLs as advocates for products• Guided and supervised the redesign of various marketing materials, including website content, print materials, and social media marketing.• Conducted competitive analysis for partnership acquisition. • Represented the company at key scientific conferences symposium and attended partnering meetings. -
Market Segment Leader, OncologyPerkinelmer Sep 2010 - Dec 2013Shelton, Ct, Us• Drove business development by establishing Oncology Market Strategy within the Diagnostics Division.• Established operating plan goals for cancer diagnostics products, ranging from $500K – 1M.• Launched hematological malignancy focused microarray platform (20+ new customers).• Coordinated and executed various activities that included KOL interviews, reimbursement strategy, go to market readiness with cross-functional teams (clinical validation, marketing/sales, senior management), and sales force training.• Collaborated with KOLs regarding product advocacy and education efforts. • Presented product specific talks at meetings and NCI Cancer Centers (Grand Rounds/Tumor Boards).• Dictated product placement at trade shows, educational seminars, and print/web media.• Formed and developed a clinical dossier and relationships with internal and external stakeholders for reimbursement.• Orchestrated, coordinated, and oversaw clinical validity and clinical trial programs at three well-known cancer centers. • Contributed to the Next Generation Sequencing diagnostics portfolio by working with PerkinElmer’s CLIA certified NGS lab to plan entry into diagnostic sequencing.• Leveraged KOL relationships for NGS sales opportunities and established NGS platform vendor relationships.• Represented PerkinElmer on the Molecular Pathology Coding and Next Generation Sequencing Workgroup. -
Product SpecialistPerkinelmer Jan 2008 - Sep 2010Shelton, Ct, Us• Tasked with technical/sales support for Molecular Diagnostics products.• Assisted and supported customers and the sales organization in the area of Array Comparative Genomic Hybridization (CGH).• Authored and published three application notes in 2008 (Applications: Stem Cells, Oncology, and Developmental Delay).• Provided extensive customer support that included training, technical seminars, and troubleshooting (20+ seminars/year).
-
Senior ScientistPerkinelmer Las Nov 2005 - Nov 2007Shelton, Ct, Us• Charged with applications support for Functional Genomic/Proteomic products.• Published applications notes for piezoelectric printing and fluorescent scanners. • Played a key role in R&D for product improvements on aCGH products.• Incorporated the voice of customer interviews to define R&D product pipeline for array CGH products.• Supervised assay development in the area of protein/peptide microarrays.• Optimized conditions for piezoelectric deposition of antibodies on glass slides.• Developed sandwich type assays for the quantitative monitoring of key signal transduction proteins.• Responsible for SBIR phase I grant data and report submission as well as phase II proposal.
-
Senior ScientistEpitome Biosystems Apr 2004 - Nov 2005UsResponsible for assay development in the area of protein/peptide microarrays• Optimized conditions for piezoelectric deposition of antibodies on glass slides• Developed sandwich type assays for the quantitative monitoring of key signal transduction proteins• Responsible for SBIR phase I grant data and report submission as well as phase II proposal -
Scientist IiMillennium Pharmaceuticals Apr 1996 - Dec 2003Cambridge, Ma, UsResponsible for development and implementation of new technologies in the area of protein/protein interactions and proteomics, with an emphasis on biosensors• Developed novel interface for the analysis of proteins bound to biosensor surfaces by mass spectrometry• Developed novel assay for GPCR “de-orphaning” using biosensor surfaces and mass spectrometry. Allowed for the discovery of possible novel GPCR ligands in less than two months• Developed assays that predicted the plasma binding properties of small molecules in a high throughput mode. Increased the number of drugs screened from 5-10 a week to 100 per day• Prepared numerous intramural and extramural project proposals and gained corporate approval • Participated in the assessment of the current and future needs for new technologies in the molecular validation of targets. Assisted in the design and implementation of ‘proof-of-concept’ studies• Supervised and advised personnel as both direct and indirect reports on team and core technology groups• Project leader for international co-development project for an array biosensor -
ScientistSandoz Pharmaceuticals Feb 1993 - Apr 1996Basel, Basel-Stadt, Ch• Designed and validated high throughput assays for drug discovery in oncology.• Developed assay platforms for target validation and screening of small molecules for oncology candidates (PCR, Cloning & Expression, IP & Western Blots).• Introduced surface plasmon resonance biosensors as a tool for target validation and assay development Implemented Biacore® for use in mutation analysis of BCR/Abl binding peptides as well as kinetic analysis of lead oncology targets binding to phosphotyrosine containing peptides. • Assessed the current and future needs for new technologies in the molecular validation of targets and oversaw the design and implementation of the ‘proof-of-concept’ studies. -
ScientistSchering-Plough Research Institute Jan 1990 - Feb 1993Kenilworth, New Jersey, Us• Functioned as a contributing member of the teams responsible for various research projects for drug development in tumor biology.• Responsible for protein expression and purification for the RAS p21 project. Expressed in E. coli, baculovius, and mammalian cell lines.• Set up in vitro and in vivo secondary assays to screen and validate lead compounds for ant-tumor activity.• Small animal handling and surgery (mice, rats, and rabbits) for drug studies and antibody production.
Christopher Williams Skills
Christopher Williams Education Details
-
Clemson UniversityBiochemistry -
Clemson UniversityMicrobiology/Molecular Biology
Frequently Asked Questions about Christopher Williams
What company does Christopher Williams work for?
Christopher Williams works for Multiple Myeloma Research Foundation - Mmrf
What is Christopher Williams's role at the current company?
Christopher Williams's current role is VP Business Development.
What is Christopher Williams's email address?
Christopher Williams's email address is ch****@****mer.com
What schools did Christopher Williams attend?
Christopher Williams attended Clemson University, Clemson University.
What are some of Christopher Williams's interests?
Christopher Williams has interest in Children.
What skills is Christopher Williams known for?
Christopher Williams has skills like Biotechnology, Assay Development, Genomics, Drug Discovery, Oncology, Life Sciences, Genetics, Molecular Biology, Molecular Diagnostics, Biochemistry, Cancer, Pcr.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial